Liraglutide, a Once-Daily Human GLP-1 Analog, Is Equally Effective and Tolerated Independent of Administration Time (Morning vs Evening)

被引：0
作者：
Kaku, Kohei
Rasmussen, Mads
Katayama, Yasuyuki
Seino, Yutaka
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A144 / A144
页数：1
相关论文
共 50 条
[21]   The Relationship between Pharmacokinetics of the Once-Daily Human GLP-1 Analog Liraglutide and Pharmacodynamic Effects on Glycemia, Gastric Emptying and Energy Intake [J].
Flint, Anne ;
Hindsberger, Charlotte .
DIABETES, 2010, 59 :A420-A420
[22]   Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes [J].
Seino, Y. ;
Rasmussen, M. F. ;
Nishida, T. ;
Kaku, K. .
CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) :1013-1022
[23]   Effects of the once-daily human GLP-1 analogue liraglutide on appetite and energy intake in type 2 diabetes [J].
Horowitz, M. ;
Flint, A. ;
Doran, S. ;
Rasmussen, M. F. ;
Kapitza, C. ;
Andreasen, A. H. ;
Jones, K. L. ;
Zdravkovic, M. ;
Chapman, I. M. .
DIABETOLOGIA, 2008, 51 :S355-S355
[24]   Absence of QTc Prolongation in a Thorough QT Study With Subcutaneous Liraglutide, a Once-Daily Human GLP-1 Analog for Treatment of Type 2 Diabetes [J].
Chatterjee, Dhruba J. ;
Khutoryansky, Naum ;
Zdravkovic, Milan ;
Sprenger, Craig R. ;
Litwin, Jeffrey S. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (11) :1353-1362
[25]   BAMBUTEROL IN THE TREATMENT OF ASTHMA - A PLACEBO-CONTROLLED COMPARISON OF ONCE-DAILY MORNING VS EVENING ADMINISTRATION [J].
DALONZO, GE ;
SMOLENSKY, MH ;
FELDMAN, S ;
GNOSSPELIUS, Y ;
KARLSSON, K .
CHEST, 1995, 107 (02) :406-412
[26]   The Pharmacokinetics, Pharmacodynamics, and Tolerability of Liraglutide, a Once-Daily Human GLP-1 Analogue, After Multiple Subcutaneous Administration in Healthy Chinese Male Subjects [J].
Jiang, Ji ;
Zhang, Jianyan ;
Jacobsen, Lisbeth V. ;
Hu, Pei .
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (12) :1620-1627
[27]   The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels [J].
Flint, Anne ;
Kapitza, Christoph ;
Hindsberger, Charlotte ;
Zdravkovic, Milan .
DIABETES, 2008, 57 :A165-A165
[28]   The once-daily human GLP-1 analogue liraglutide improves both absolute and baseline corrected postprandial glucose levels [J].
Flint, A. ;
Kapitza, C. ;
Hindsberger, C. ;
Zdravkovic, M. .
DIABETOLOGIA, 2008, 51 :S354-S354
[29]   The once-daily human GLP-1 analog liraglutide reduces body weight in subjects with type 2 diabetes, irrespective of body mass index at baseline [J].
Russell-Jones, David ;
Shaw, Jonathan E. ;
Brandle, Michael ;
Matthews, David ;
Frid, Anders ;
Zdravkovic, Milan ;
Schmitz, Ole .
DIABETES, 2008, 57 :A593-A594
[30]   Treatment with Liraglutide, a Once-Daily Human GLP-1 Analog, for 52 Weeks Reduces Weight and Waist Circumference: A Randomized Placebo-Controlled Trial [J].
Astrup, Arne ;
Al Hakim, Mazin ;
Savolainen, Markku J. ;
Van Gaal, Luc ;
Finer, Nick ;
Harper, Angela ;
Lean, Michael E. J. ;
Niskanen, Leo ;
Frederik, Mads ;
Rissanen, Aila ;
Rossner, Stephan .
OBESITY, 2009, 17 :S51-S51
12345